Mitochondrial Disorders (mtDNA) Sequencing
2006065
 
Ordering Recommendation
Mnemonic
MT SEQ
Methodology
Massive Parallel Sequencing
Performed
Varies
Reported
Within 12 weeks
New York DOH Approval Status
Specimens from New York clients will be sent out to a New York DOH approved laboratory.
Specimen Required
Patient Preparation
 
Collect
Lavender (EDTA), pink (K2EDTA), or yellow (ACD solution A or B). Peripheral blood required.  
Specimen Preparation
Transport 3 mL whole blood. (Min: 1 mL)  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
 
Remarks
Submit the Patient History Form for Mitochondrial Disorders Studies with the Electronic Packing List.  
Stability
Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable  
Reference Interval
By report
Interpretive Data
Refer to report.



Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com.

See Compliance Statement C: www.aruplab.com/CS
Note
CPT Code(s)
81403 (MT-RNR1), 81403 (MT-TS1), 81479 (1)
Components
Component Test Code*Component Chart Name
2006066Mitochondrial Disorders Seq. Specimen
2006067Mitochondrial Disorders Seq. Interp.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, contact interface support at interface.support@aruplab.com.
Cross References